Skip to content
healthcare.dev

Levothyroxine Sodium

NDC 63323-647, LEVOTHYROXINE SODIUM ANHYDROUS, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-647
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202231
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-647 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM ANHYDROUS200 ug/5mL

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
63323-647-10633230647101 VIAL, SINGLE-DOSE in 1 CARTON (63323-647-10) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ce990712-49c1-4f66-9ee4-c770e8ec394c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-647

Use it

Look up 63323-647 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-647 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-647. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.